Published in Lab Business Week, February 5th, 2006
"Affymetrix is experiencing growing pains as it both innovates and commercializes new products in high potential markets. Introduced about 2 years ago, our DNA analysis business has grown to around $90 million in fiscal 2005," stated Stephen P.A. Fodor, PhD, founder, chairman and CEO of Affymetrix.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.